NEW YORK, Nov. 14 – Belgian functional genomics company Galapagos Genomics said Wednesday that it had agreed to build a gene library for Pharmacia designed to help the pharmaceutical company to identify and validate drug targets for a range of diseases.

Galapagos has developed the PhenoSelect expression platform, which uses arrayed adenoviruses containing human genes to identify and validate targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.